Rare genetic diseases are a classic example of where motivated patients (and parents of patients) can do their own research and make a difference. Sequencing is getting cheap enough for individuals to afford, but hasn’t yet been commoditized that well, so hustling and asking for special favors is useful here. And, of course, if your disease is rare, there isn’t a huge market for treating it.
Matt Might is a famous example of a software engineer who identified and found a treatment for his son’s rare genetic disorder.
In addition to being a skilled software engineer, Matt Might is now a professor, endowed chair, and director of an institute of personalized medicine at University of Alabama’s school of medicine. Before that, he was a professor of computer science at the University of Utah.
Rare genetic diseases are a classic example of where motivated patients (and parents of patients) can do their own research and make a difference. Sequencing is getting cheap enough for individuals to afford, but hasn’t yet been commoditized that well, so hustling and asking for special favors is useful here. And, of course, if your disease is rare, there isn’t a huge market for treating it.
Matt Might is a famous example of a software engineer who identified and found a treatment for his son’s rare genetic disorder.
In addition to being a skilled software engineer, Matt Might is now a professor, endowed chair, and director of an institute of personalized medicine at University of Alabama’s school of medicine. Before that, he was a professor of computer science at the University of Utah.